Bernstein analyst, Mark Moerdler, reiterated his Underperform rating on shares of salesforce.com (NYSE: CRM) and raised his price target to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst EPS Change Analyst EPS View Analyst PT Change

salesforce.com (CRM) PT Raised to $110 at Canaccord Genuity on 2Q Beat; 'Good Print, Conservative Q3 Deferred Guide... If Stock Stays Down, Buy It'August 23, 2017 10:26 AM salesforce.com (CRM) PT Raised to $105 at BMO Capital on 2Q Report; 'Raise Our Confidence in CRM to Sustain Almost 20% Revenue Growth'August 23, 2017 8:58 AM